Dr. Allan Levey Receives NIH AD grant for $7.2M

Dr. Allan Levey Receives NIH AD grant for $7.2M

  Dr. Allan Levey, MD, Ph.D., of Emory University, has received a grant from the National Institutes of Health (NIH) for $7.2M for Alzheimer’s disease research.  The purpose of this study is to discover proteins ‘beyond the usual suspects of beta-amyloid and tau’...
Dr. Kurt Brunden

Dr. Kurt Brunden

Research Associate Professor Scientific Director, Marian S. Ware Alzheimer and Benaroya Parkinson’s Disease Drug Discovery Programs Dr. Burnden’s proposal is close behind Puglieli’s in terms of proximity to animal model testing, after Brunden does some...
MAYO JAX – Dr. Malcolm Leissering

MAYO JAX – Dr. Malcolm Leissering

The Leissering lab studies substances (called proteases) that destroy amyloid beta-protein which is the chief component of the plaques that create Alzheimer’s disease. Dr. Leissring previous work has shown that the severity of Alzheimer’s Disease is...